Now showing items 1-4 of 4
The Palliative Radiotherapy and Inflammation Study (PRAIS) - Protocol for a longitudinal observational multicenter study on patients with cancer induced bone pain 11 Medical and Health Sciences 1103 Clinical Sciences
(Journal article; Tidsskriftartikkel; Peer reviewed, 2018-09-28)
<i><p>Background</i>: Radiation therapy (RT) results in pain relief for about 6 of 10 patients with cancer induced bone pain (CIBP) caused by bone metastases. The high number of non-responders, the long median time from RT to pain response and the risk of adverse effects, makes it important to determine predictors of treatment response. Clinical features such as cancer type, performance status and ...
Lindring av smerter hos kreftpasienter
(Research report; Forskningsrapport, 2005)
Denne rapporten er en bestilling fra tidligere Sosial-og helsedepartementet om å vurdere kunnskapsgrunnlaget om effekt av palliativ smertebehandling ved kreft, dvs. Effekt av ulike behandlingsmetoder for å lindre smerter hos pasienter med uhelbredelig (ikke-kurabel) kreftsykdom.
Tumour size reduction after the first chemotherapy-course and outcomes of chemoradiotherapy in limited disease small-cell lung cancer
(Journal article; Tidsskriftartikkel; Peer reviewed, 2016-10-15)
Objectives: <br> Concurrent chemotherapy and thoracic radiotherapy (TRT) is recommended for limited disease small-cell lung cancer (LD SCLC). TRT should start as early as possible, often meaning with the second course due to patient referral time and the fact that TRT planning takes time. Early assessment of response to the first course of chemotherapy may be a useful way to individualise treatment. ...
Comorbidity and outcomes of concurrent chemo- and radiotherapy in limited disease small cell lung cancer
(Journal article; Tidsskriftartikkel; Peer reviewed, 2016-08-23)
<b>Background:</b> Many patients with limited disease small cell lung cancer (LD SCLC) suffer from comorbidity. Not all patients with comorbidity are offered standard treatment, though there is little evidence for such a policy. The aim of this study was to investigate whether patients with comorbidity had inferior outcomes in a LD SCLC cohort. <br><b>Material and methods:</b> We analyzed patients ...